Evidence map›Paper›PMID 31712268›Full record

ArticleInfection and immunity2020

The Other Side of the Coin: Anti-inflammatory Antibody Therapy for Infectious Diseases.

David L Goldman

Open access · greenAbstract readComment
In one paragraph

Article in Infection and immunity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

David L GoldmanDepartment of Pediatrics, The Children's Hospital at Montefiore and the Albert Einstein College of Medicine, Bronx, New York, USA David.Goldman@einstein.yu.edu.
Children's Hospital at Montefiore · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The inflammatory response to the fungus

Indexed as

PneumocystisPneumonia, PneumocystisAnti-Inflammatory AgentsHumansImmunotherapySulfasalazineAnti-Inflammatory AgentsSulfasalazineinflammationmonoclonal antibodiesPneumocystis carinii

Identifiers

PMID31712268
PMCPMC6977120
OpenAlexW2983897916

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.